240 related articles for article (PubMed ID: 7477355)
1. AIDS vaccine 'needs focused effort' as drug firms back off research.
Butler D
Nature; 1995 Nov; 378(6555):323-4. PubMed ID: 7477355
[No Abstract] [Full Text] [Related]
2. HIV/AIDS: money matters.
Roberts L; Jasny B
Science; 2008 Jul; 321(5888):511. PubMed ID: 18653875
[No Abstract] [Full Text] [Related]
3. The AIDS vaccine: back to the basics?
Naper J
Hosp Technol Ser; 1994 Nov; 13(14):11-2. PubMed ID: 10139025
[No Abstract] [Full Text] [Related]
4. A developing theme for AIDS.
Watanabe M
Nature; 2003 Dec; 426(6967):736-7. PubMed ID: 14668887
[No Abstract] [Full Text] [Related]
5. Endgame for MicroGeneSys vaccine trial?
Science; 1993 Dec; 262(5140):1635. PubMed ID: 8259501
[No Abstract] [Full Text] [Related]
6. Designing the financial tools to promote universal access to AIDS care.
Leoni P; Luchini S
J Health Econ; 2011 Jan; 30(1):181-8. PubMed ID: 21126788
[TBL] [Abstract][Full Text] [Related]
7. Funds earmarked for AIDS vaccine centre.
Nature; 1997 Aug; 388(6642):510. PubMed ID: 9252178
[No Abstract] [Full Text] [Related]
8. Betting big on an AIDS vaccine.
Nat Med; 2005 Jun; 11(6):579. PubMed ID: 15937450
[No Abstract] [Full Text] [Related]
9. Vaccine development moves to front burner.
AIDS Alert; 1997 Mar; 12(3):32-3. PubMed ID: 11364191
[TBL] [Abstract][Full Text] [Related]
10. National Institute of Allergy and Infectious Diseases names key new components of HIV/AIDS research networks.
J Investig Med; 2007 May; 55(4):154. PubMed ID: 17651666
[No Abstract] [Full Text] [Related]
11. Steering a course to an AIDS vaccine.
Baltimore D
Science; 2002 Jun; 296(5577):2297. PubMed ID: 12089410
[No Abstract] [Full Text] [Related]
12. Immunology. New virtual center aims to speed AIDS vaccine progress.
Cohen J
Science; 2005 Jul; 309(5734):541. PubMed ID: 16040673
[No Abstract] [Full Text] [Related]
13. NIAID funds new groups to develop HIV vaccines.
Watanabe ME
Nat Med; 2000 Aug; 6(8):844. PubMed ID: 10932202
[No Abstract] [Full Text] [Related]
14. NIAID collaborates with VaxGen on vaccine studies.
AIDS Patient Care STDS; 1998 Nov; 12(11):874. PubMed ID: 11362049
[No Abstract] [Full Text] [Related]
15. AIDS vaccine research focuses on subtypes in developed world.
Sharma R
BMJ; 2000 Sep; 321(7264):787. PubMed ID: 11009513
[No Abstract] [Full Text] [Related]
16. Texas' AIDS care still unraveling.
Zoler ML
Med World News; 1988 Jun; 29(11):59-60. PubMed ID: 10287670
[No Abstract] [Full Text] [Related]
17. Panel calls for overhaul of AIDS research.
Wadman M
Nature; 1996 Mar; 380(6571):190. PubMed ID: 8637561
[No Abstract] [Full Text] [Related]
18. The AIDS initiative, one year later.
Franke-Ruta G
Natl J (Wash); 1998 May; 30(19):1062-3. PubMed ID: 10179877
[No Abstract] [Full Text] [Related]
19. Agencies spar over vaccine trial.
Cohen J
Science; 1993 Feb; 259(5096):752-3. PubMed ID: 8430324
[No Abstract] [Full Text] [Related]
20. Petition fails to reverse massive price rise for AIDS drug.
Check E
Nature; 2004 Aug; 430(7001):715. PubMed ID: 15306778
[No Abstract] [Full Text] [Related]
[Next] [New Search]
